C. Randal Mills
2009 - Osiris Therapeutics
In 2009, C. Randal Mills earned a total compensation of $974K as President and Chief Executive Officer at Osiris Therapeutics, a 24% decrease compared to previous year.
Compensation breakdown
| Bonus | $160,000 |
|---|---|
| Option Awards | $368,550 |
| Salary | $445,441 |
| Total | $973,991 |
Mills received $445.4K in salary, accounting for 46% of the total pay in 2009.
Mills also received $160K in bonus and $368.6K in option awards.
Rankings
In 2009, C. Randal Mills' compensation ranked 4,556th out of 9,885 executives tracked by ExecPay. In other words, Mills earned more than 53.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,556 out of 9,885 | 54th |
Division Manufacturing | 1,621 out of 3,690 | 56th |
Major group Chemicals And Allied Products | 322 out of 871 | 63rd |
Industry group Drugs | 195 out of 643 | 70th |
Industry Biological Products, Except Diagnostic Substances | 34 out of 138 | 75th |
Source: SEC filing on April 27, 2012.
Mills' colleagues
We found five more compensation records of executives who worked with C. Randal Mills at Osiris Therapeutics in 2009.
2009
Lode Debrabandere
Osiris Therapeutics
Senior Vice President,
2009
Therapeutics Williams
Osiris Therapeutics
Chief Scientific Officer
2009
Richard Hunt
Osiris Therapeutics
Chief Financial Officer
2009
Philip Jacoby
Osiris Therapeutics
Chief Financial Officer
2009
Harry Carmitchel
Osiris Therapeutics